These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34725618)

  • 1. A Cross-Sectional Study for Prevalence and Association of Risk Factors of Chronic Kidney Disease Among People With Type 2 Diabetes in the Indian Setting.
    Tewari A; Tewari V; Tewari J
    Cureus; 2021 Sep; 13(9):e18371. PubMed ID: 34725618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kidney disease progression and all-cause mortality across estimated glomerular filtration rate and albuminuria categories among patients with vs. without type 2 diabetes.
    Nichols GA; Déruaz-Luyet A; Brodovicz KG; Kimes TM; Rosales AG; Hauske SJ
    BMC Nephrol; 2020 May; 21(1):167. PubMed ID: 32380961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors and urinary biomarkers of non-albuminuric and albuminuric chronic kidney disease in patients with type 2 diabetes.
    Korbut AI; Klimontov VV; Vinogradov IV; Romanov VV
    World J Diabetes; 2019 Nov; 10(11):517-533. PubMed ID: 31798788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An observational, cross-sectional study to assess the prevalence of chronic kidney disease in type 2 diabetes patients in India (START -India).
    Prasannakumar M; Rajput R; Seshadri K; Talwalkar P; Agarwal P; Gokulnath G; Kotak B; Raza A; Vasnawala H; Teli C
    Indian J Endocrinol Metab; 2015; 19(4):520-3. PubMed ID: 26180769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parallel assessment of albuminuria and plasma sTNFR1 in people with type 2 diabetes and advanced chronic kidney disease provides accurate prognostication of the risks of renal decline and death.
    Martin WP; Tuohy C; Doody A; Jackson S; Canavan RJ; Slattery D; Twomey PJ; McKenna MJ; le Roux CW; Docherty NG
    Sci Rep; 2020 Sep; 10(1):14852. PubMed ID: 32908199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in GFR and Albuminuria in Routine Clinical Practice and the Risk of Kidney Disease Progression.
    Neuen BL; Weldegiorgis M; Herrington WG; Ohkuma T; Smith M; Woodward M
    Am J Kidney Dis; 2021 Sep; 78(3):350-360.e1. PubMed ID: 33895181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kidney Function as Risk Factor and Predictor of Cardiovascular Outcomes and Mortality Among Older Adults.
    Kühn A; van der Giet M; Kuhlmann MK; Martus P; Mielke N; Ebert N; Schaeffner ES
    Am J Kidney Dis; 2021 Mar; 77(3):386-396.e1. PubMed ID: 33197533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial.
    Heerspink HJL; Jongs N; Chertow GM; Langkilde AM; McMurray JJV; Correa-Rotter R; Rossing P; Sjöström CD; Stefansson BV; Toto RD; Wheeler DC; Greene T;
    Lancet Diabetes Endocrinol; 2021 Nov; 9(11):743-754. PubMed ID: 34619108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barriers to initiating SGLT2 inhibitors in diabetic kidney disease: a real-world study.
    Jeong SJ; Lee SE; Shin DH; Park IB; Lee HS; Kim KA
    BMC Nephrol; 2021 May; 22(1):177. PubMed ID: 33990175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of estimated glomerular filtration rate and urine albumin-to-creatinine ratio with incidence of cardiovascular diseases and mortality in chinese patients with type 2 diabetes mellitus - a population-based retrospective cohort study.
    Fung CS; Wan EY; Chan AK; Lam CL
    BMC Nephrol; 2017 Feb; 18(1):47. PubMed ID: 28152985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normality data of eGFR and validity of commonly used screening tests for CKD in an area with endemic CKD of unknown etiology; need for age and sex based precise cutoff values.
    Herath N; Dassanayake R; Dissanayake M; Janitha C; Weerakoon K; Kumarasinghe C; de Silva TG; Agampodi S
    BMC Nephrol; 2019 Aug; 20(1):298. PubMed ID: 31382902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity and Kidney Function: A Two-Sample Mendelian Randomization Study.
    Kjaergaard AD; Teumer A; Witte DR; Stanzick KJ; Winkler TW; Burgess S; Ellervik C
    Clin Chem; 2022 Mar; 68(3):461-472. PubMed ID: 34922334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonalbuminuric Diabetic Kidney Disease and Risk of All-Cause Mortality and Cardiovascular and Kidney Outcomes in Type 2 Diabetes: Findings From the Hong Kong Diabetes Biobank.
    Jin Q; Luk AO; Lau ESH; Tam CHT; Ozaki R; Lim CKP; Wu H; Jiang G; Chow EYK; Ng JK; Kong APS; Fan B; Lee KF; Siu SC; Hui G; Tsang CC; Lau KP; Leung JY; Tsang MW; Kam G; Lau IT; Li JK; Yeung VT; Lau E; Lo S; Fung S; Cheng YL; Chow CC; Huang Y; Lan HY; Szeto CC; So WY; Chan JCN; Ma RCW;
    Am J Kidney Dis; 2022 Aug; 80(2):196-206.e1. PubMed ID: 34999159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease.
    Rossing P; Baeres FMM; Bakris G; Bosch-Traberg H; Gislum M; Gough SCL; Idorn T; Lawson J; Mahaffey KW; Mann JFE; Mersebach H; Perkovic V; Tuttle K; Pratley R
    Nephrol Dial Transplant; 2023 Aug; 38(9):2041-2051. PubMed ID: 36651820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between 1-year changes in urinary albumin-to-creatinine ratio and kidney disease progression in Japanese individuals with diabetes: a historical cohort study.
    Babazono T; Hanai K; Yokoyama Y; Uchiyama K
    Clin Exp Nephrol; 2023 Dec; 27(12):1001-1009. PubMed ID: 37606804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and functional assessment of the brain in European Americans with mild-to-moderate kidney disease: Diabetes Heart Study-MIND.
    Murea M; Hsu FC; Cox AJ; Hugenschmidt CE; Xu J; Adams JN; Raffield LM; Whitlow CT; Maldjian JA; Bowden DW; Freedman BI
    Nephrol Dial Transplant; 2015 Aug; 30(8):1322-9. PubMed ID: 25722384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association of thyroid parameters with markers of chronic kidney disease in euthyroid patients with type 2 diabetes.
    Shi W; Song D; Chen D; Duan W; Zhang J
    Endocr J; 2023 Jul; 70(7):687-696. PubMed ID: 37081693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kidney dysfunction: prevalence and associated risk factors in a community-based study from the North West Province of South Africa.
    Navise NH; Mokwatsi GG; Gafane-Matemane LF; Fabian J; Lammertyn L
    BMC Nephrol; 2023 Jan; 24(1):23. PubMed ID: 36717778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Finerenone and Heart Failure Outcomes by Kidney Function/Albuminuria in Chronic Kidney Disease and Diabetes.
    Filippatos G; Anker SD; Pitt B; Rossing P; Joseph A; Kolkhof P; Lambelet M; Lawatscheck R; Bakris GL; Ruilope LM; Agarwal R
    JACC Heart Fail; 2022 Nov; 10(11):860-870. PubMed ID: 36328655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploration of chronic kidney disease prevalence estimates using new measures of kidney function in the health survey for England.
    Fraser SD; Aitken G; Taal MW; Mindell JS; Moon G; Day J; O'Donoghue D; Roderick PJ
    PLoS One; 2015; 10(2):e0118676. PubMed ID: 25700182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.